Tokyo Tape
Sign in
← Jeol

Quarterly report · Q2

6951.TEDINET S100PKJL
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥64.7bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥138.4bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥53.4bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥6.9bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥3.7bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥8.8bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥16.3bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.7bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥9.6bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥4.8bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥7.2bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥12.3bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.7bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥7.2bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥3.7bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥189.8bnat 2022-09-30Cons.Assets
Total assets¥189.6bnat 2022-03-31Cons.Assets
Total assets¥168.3bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥97.1bnat 2022-09-30Cons.Liabilities
Total liabilities¥103.7bnat 2022-03-31Cons.Liabilities
Net assets / equity¥92.7bnat 2022-09-30Cons.Net assets
Net assets / equity¥85.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥77.4bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥39.3bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥44.2bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥37.2bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥42.4bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥30.2bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥14.5bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥2.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥22.6bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥5.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥3.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥648m2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥438m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥4.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥5.5bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥11.3bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥141.672022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥78.632022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥246.782021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥75.562021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥59.592021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio48.8%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio45.3%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio46.0%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥2.6bn
jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segmentrevenue2022-04-01 → 2022-09-30¥20.5bn
jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segmentrevenue external2022-04-01 → 2022-09-30¥20.5bn
jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segmentsegment profit2022-04-01 → 2022-09-30¥9.3bn
jpcrp040300-q2r_E01905-000Medical Equipmentreportable segmentrevenue2022-04-01 → 2022-09-30¥8.5bn
jpcrp040300-q2r_E01905-000Medical Equipmentreportable segmentrevenue external2022-04-01 → 2022-09-30¥8.5bn
jpcrp040300-q2r_E01905-000Medical Equipmentreportable segmentsegment profit2022-04-01 → 2022-09-30¥270m
jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segmentrevenue2022-04-01 → 2022-09-30¥35.8bn
jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segmentrevenue external2022-04-01 → 2022-09-30¥35.8bn
jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segmentsegment profit2022-04-01 → 2022-09-30−¥81m
—segment totalrevenue2022-04-01 → 2022-09-30¥64.7bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥64.7bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥9.5bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥2.3bn
jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segmentrevenue2021-04-01 → 2021-09-30¥14.5bn
jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segmentrevenue external2021-04-01 → 2021-09-30¥14.5bn
jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segmentsegment profit2021-04-01 → 2021-09-30¥5.8bn
jpcrp040300-q2r_E01905-000Medical Equipmentreportable segmentrevenue2021-04-01 → 2021-09-30¥9.4bn
jpcrp040300-q2r_E01905-000Medical Equipmentreportable segmentrevenue external2021-04-01 → 2021-09-30¥9.4bn
jpcrp040300-q2r_E01905-000Medical Equipmentreportable segmentsegment profit2021-04-01 → 2021-09-30¥820m
jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segmentrevenue2021-04-01 → 2021-09-30¥29.5bn
jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segmentrevenue external2021-04-01 → 2021-09-30¥29.5bn
jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segmentsegment profit2021-04-01 → 2021-09-30−¥670m
—segment totalrevenue2021-04-01 → 2021-09-30¥53.4bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥53.4bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥6.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 553
ItemContextValueUnit
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration53368000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E01905-000ScientificAndMeasurementInstrumentsReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E01905-000IndustrialEquipmentReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E01905-000MedicalEquipmentReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E01905-000ScientificAndMeasurementInstrumentsReportableSegmentsMember29476000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E01905-000IndustrialEquipmentReportableSegmentsMember14537000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E01905-000MedicalEquipmentReportableSegmentsMember9354000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember53368000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember－JPY
Net salesPrior1YTDDuration53368000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E01905-000ScientificAndMeasurementInstrumentsReportableSegmentsMember-670000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E01905-000IndustrialEquipmentReportableSegmentsMember5814000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E01905-000MedicalEquipmentReportableSegmentsMember820000000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember5965000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-2288000000JPY
Operating incomePrior1YTDDuration3676000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E01905-000ScientificAndMeasurementInstrumentsReportableSegmentsMember35771000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E01905-000IndustrialEquipmentReportableSegmentsMember20467000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E01905-000MedicalEquipmentReportableSegmentsMember8504000000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember64743000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration64743000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E01905-000ScientificAndMeasurementInstrumentsReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E01905-000IndustrialEquipmentReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E01905-000MedicalEquipmentReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E01905-000ScientificAndMeasurementInstrumentsReportableSegmentsMember35771000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E01905-000IndustrialEquipmentReportableSegmentsMember20467000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E01905-000MedicalEquipmentReportableSegmentsMember8504000000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember64743000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember－JPY
Net salesCurrentYTDDuration64743000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E01905-000ScientificAndMeasurementInstrumentsReportableSegmentsMember-81000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E01905-000IndustrialEquipmentReportableSegmentsMember9325000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E01905-000MedicalEquipmentReportableSegmentsMember270000000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember9514000000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-2604000000JPY
Operating incomeCurrentYTDDuration6909000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2022-11-11
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第76期第２四半期（自　2022年７月１日　至　2022年９月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)日本電子株式会社

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass